SKAN Group AG, the Swiss-based isolator systems specialist listed on the SIX Swiss Exchange, has issued a statement acknowledging first-instance judgments delivered by Switzerland's Federal Criminal Court on 17 November 2026. The company's Chief Financial Officer has lodged a notice of appeal against a first-instance conviction, meaning the case against him remains legally unresolved. Separately, the Head of the Services, Digital & Single-Use Systems Segment was acquitted of a charge related to exploiting insider information. SKAN's Board of Directors confirmed it continues to monitor the situation closely.

Key Points

  • SKAN Group AG (0SKN), listed on the SIX Swiss Exchange under ISIN CH0013396012
  • Federal Criminal Court issued first-instance judgments on 17 November 2026 involving two senior SKAN executives
  • CFO has filed a notice of appeal; the Head of Services, Digital & Single-Use Systems Segment was acquitted of exploiting insider information
  • Investors should watch for further developments in the CFO's appeal proceedings and SKAN's preliminary 2026 financial figures, due 28 January 2027

SKAN CFO Remains in Post as Appeal Against First-Instance Conviction Proceeds

SKAN Group AG confirmed that its CFO has given notice of appeal against the first-instance conviction handed down by the Federal Criminal Court. Because the appeal has been lodged, the proceedings against the CFO have not yet reached a legally binding conclusion. The company's announcement explicitly states that the presumption of innocence continues to apply and that the CFO remains in his current position. SKAN added that it has the greatest interest in the ongoing proceedings being concluded as quickly as possible, with the Board of Directors continuing to monitor the situation closely.

Head of Services, Digital & Single-Use Systems Segment Acquitted of Insider Information Charge

In contrast to the CFO's situation, the Head of SKAN's Services, Digital & Single-Use Systems Segment received a full acquittal from the Federal Criminal Court on the charge of exploiting insider information. The announcement does not provide further detail on the nature of the original allegation or the court's reasoning. The Services, Digital & Single-Use Systems Segment forms part of SKAN's broader offering, which extends beyond its core isolator systems business to encompass process support, software, services, and single-use systems for the pharmaceutical and biotech industries.

SKAN's Role as Isolator Systems Leader for the Global (Bio)Pharmaceutical Industry

Founded in 1968 and headquartered in Allschwil within the Basel region Life Sciences Hub, SKAN is described in the announcement as a pioneer and market and technology leader in aseptic and aseptic-toxic manufacturing processes for the (bio)pharmaceutical industry. The company employs around 1,700 people across subsidiaries in Switzerland, Germany, Belgium, France, Slovenia, Croatia, Japan, the United States, and Brazil. Its customer base includes pharmaceutical companies, biotech firms, contract manufacturing organisations, and research laboratories worldwide.

SKAN Financial Calendar: Preliminary 2026 Figures Due 28 January 2027

Alongside the legal update, SKAN's announcement sets out key upcoming investor dates. Preliminary key figures for the 2026 financial year are scheduled for publication on 28 January 2027, followed by the full Annual Results 2026 on 23 March 2027. The Annual General Meeting 2027 is set for 28 April 2027. Investors following the company will likely focus on whether the CFO's appeal proceedings reach a resolution before the annual results publication, and on any operational commentary accompanying the preliminary figures.